Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Taxes (2016 - 2025)

Pediatrix Medical (MD) has disclosed Change in Taxes for 17 consecutive years, with -$10.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Taxes rose 15.7% to -$10.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 75.9% increase, with the full-year FY2025 number at -$1.2 million, up 75.9% from a year prior.
  • Change in Taxes was -$10.6 million for Q4 2025 at Pediatrix Medical, down from $4.6 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $46.7 million in Q2 2021 to a low of -$29.5 million in Q2 2022.
  • A 5-year average of -$599400.0 and a median of $2.4 million in 2025 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: soared 210.86% in 2022, then plummeted 194.82% in 2023.
  • Pediatrix Medical's Change in Taxes stood at -$18.7 million in 2021, then surged by 193.31% to $17.4 million in 2022, then plummeted by 194.82% to -$16.5 million in 2023, then rose by 23.96% to -$12.6 million in 2024, then increased by 15.7% to -$10.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Change in Taxes are -$10.6 million (Q4 2025), $4.6 million (Q3 2025), and $2.0 million (Q2 2025).